Feature Article

Atopic Dermatitis: Practical Recommendations for Step-Up Therapy


Although the step-care approach is the current standard of care, this approach is flawed in several ways with respect to achieving optimal outcomes.

The relative risk for healthcare-associated infections has decreased in the last 15 years due to improvements in awareness of risk associated with devices, infection control, and evidence-based practice regarding use of devices.

Latest News

Variation of Staphylococcus aureus Clonal Complex Type Linked to Worse Disease Activity in Atopic Dermatitis


Of patients who were colonized at both visits, 51.9% remained colonized with the same CC-type at follow-up.

Use of Bee Venom for Topical Treatment in Patients With Atopic Dermatitis


The use of bee venom and its major component, melittin, has proven suitable as an epicutaneous application for the treatment of atopic dermatitis.

Menthoxypropanediol Provides Itch Relief in Atopic Dermatitis

By Dermatology Advisor Contributing Writer

The participants were administered a skin care formulation containing menthoxypropanediol.

Atopic Dermatitis Likely Not Associated With Cardiometabolic Disease

By Dermatology Advisor Contributing Writer

Atopic dermatitis was not found to be an independent risk factor for cardiometabolic disease in this meta-analysis.

Hypersensitivity to Allergens in Personal Care Products More Common in Atopic Dermatitis


Polysensitization was reported significantly more often in patients with atopic dermatitis vs those without.

Individuals With Atopic Dermatitis More Likely to Have Antibody Response to S Aureus Superantigens

By Dermatology Advisor Contributing Writer

An immunoglobulin E (IgE) antibody response to Staphylococcus aureus superantigens is more common among individuals with atopic dermatitis than healthy controls.

Dupilumab Beneficial in Adolescent Patients With Moderate to Severe Atopic Dermatitis


The Phase 3 trial enrolled 251 patients aged 12-17 years old with moderate-to-severe atopic dermatitis, whose disease was not adequately controlled by prescription topical medications or for whom topical treatment was medically inadvisable.

Low Quality of Life, High Disease Burden Seen in Atopic Dermatitis


The study findings support the heavy burden that atopic dermatitis places on patients, particularly those with moderate and severe disease.

Stratum Corneum Samples Effective for Immune Response Analysis in Pediatric Atopic Dermatitis


Some aspects of pathophysiologic mechanisms may differ in children with atopic dermatitis with light skin types vs those with dark skin types.

Dupilumab for Atopic Dermatitis: Is the Increased Cost Worth It?


Dupilumab therapy provided an additional 1.91 quality-adjusted life years during the remaining lifetime of a patient compared with usual care.

Sign up for Newsletters